USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
INTEGRATED DNA TECHNOLOGIES, INC.
Address:
INTEGRATED DNA TECHNOLOGIES
1710 COMMERICAL PARK
CORVALVILLE, IA
Phone:
N/A
URL:
N/A
EIN:
421301142
DUNS:
1988919
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $367,773.00 3
SBIR Phase II $868,220.00 1

Award List:

Support Vector Machine modeling software for improving RNAi efficacy prediction

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$97,773.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Title Support vector machines predict sequence ~ activity relationships in RNA interference Project Summary/Abstract Support Vector Machines (SVMs) are a group of algorithms in supervised machine learning that are able to build classification or regression models… More

Predicting stability of nucleic acid duplexes containing chemical modifications

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Synthetic DNA and RNA oligomers are important tools for biological and medical assays including polymerase chain reactions, sequencing, DNA microarrays, antisense technology and RNA interference. Oligomers are generally used in experiments where they anneal to… More

Gene Silencing with U1 Adaptor Oligonucleotides

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$170,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Our understanding of complex biological phenomena and disease progression has led to the realization that changes in the expression of genes underlie many of these processes. Developing reagents that can selectively al ter the expression level of any desired… More

Optimization of U1 Adaptor Technology

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$868,220.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Our understanding of complex biological phenomena and disease progression has led to the realization that changes in the expression of genes underlie many of these processes. Developing reagents that can selectively alt er the expression level of any desired gene… More